Ratifi English Iniciar sesión
Ratifi

Proyectos federales de Congress.gov. Proyectos estatales de Open States.

HB 2684Sesión 2025-2026

Providing price limits and other requirements for health benefits covering prescription insulin drugs and establishing the insulin affordability program for the uninsured.

As Introduced

Skip to main content Kansas Legislature kslegislature.gov menu Home House account_balanceAbout the House groupsRepresentatives campaignEvents chairSeating Chart auto_storiesJournals & Calendars manage_accountsChief Clerk of the House gavelRules Senate account_balanceAbout the Senate groupsSenators campaignEvents assignment_indAppointments chairSeating Chart auto_storiesJournals & Calendars manage_accountsSecretary of the Senate gavelRules Committees groupsCommittees eventHearing Schedule handshakeConference Committee Schedule Measures & Laws gavelAll Measures account_balanceHouse Measures account_balanceSenate Measures account_balanceVotes topicSubject Index summarizeReports menu_bookStatutes schoolHow a Bill Becomes Law menu_bookLegislative Procedure Manual Today campaignLive Floor Activity videocamHouse Video videocamSenate Video live_tvStatehouse Live & Archive smart_displayYouTube Channel Resources Archive Search description Go to bill or resolution arrow_forward A− A+ search Search bills, resolutions, and statutes help

Keywords
Enter any words to search bills, statutes, and documents.
water quality funding

Bill or Resolution Number
Type a number and press Enter to go directly to the detail page.
HB 2590 SCR 1611

Statute Number
68-102 72-3715

Exact Phrase
Wrap your query in quotes.
“rules of evidence”

Document Type
Prefix with a type to narrow results.
testimony: HB 2513 minutes: budget

    Searching…

    No results found.

    search Search bills, resolutions, and statutes Home House About the House Representatives Events Seating Chart Journals & Calendars Chief Clerk of the House Rules Senate About the Senate Senators Events Appointments Seating Chart Journals & Calendars Secretary of the Senate Rules Committees All Committees Hearing Schedule Conference Committee Schedule Measures & Laws All Measures House Measures Senate Measures Votes Subject Index Reports Statutes How a Bill Becomes Law Legislative Procedure Manual Resources Today Live Floor Activity House Video Senate Video Statehouse Live & Archive YouTube Channel Archive Search
    1. HB 2684›
    2. HB 2684 — As Introduced

    Kansas Legislature

    HB 2684 — As Introduced

    picture_as_pdf Download PDF Session of 2026HOUSE BILL No. 2684By Committee on InsuranceRequested by Representative Meyer2-41AN ACT concerning health and healthcare; relating to prescription drugs; 2providing coverage for insulin drugs and diabetes management devices; 3providing price limitations and requirements therefor under health 4insurance plans.56Be it enacted by the Legislature of the State of Kansas:7Section 1. (a) Every individual or group health insurance policy, 8medical service plan, contract, hospital service corporation contract, 9hospital and medical service corporation contract, fraternal benefit society 10or health maintenance organization that provides coverage for accident and 11health services and is delivered, issued for delivery, amended or renewed 12on or after January 1, 2027, shall provide coverage for prescription insulin 13drugs in accordance with this section.14(b) All coverage for accident and health services described in 15subsection (a) shall limit the total amount that a covered person is required 16to pay for a 30-day supply for:17(1) All covered prescription insulin drugs, including any amount or 18type of insulin needed to fill the covered person's prescription and any 19number of prescriptions filled, to an amount of not to exceed $35; and20(2) all devices, to an amount of not to exceed $100.21(c) All coverage for accident and health services described in 22subsection (a) shall cover:23(1) At least one type of prescription insulin drug in each of the 24following categories:25(A) Rapid acting;26(B) ultra rapid acting;27(C) short acting;28(D) intermediate acting;29(E) long acting;30(F) pre-mixed insulin products;31(G) pre-mixed insulin/GLP-1 RA products; and32(H) concentrated human regular insulin; and33(2) diabetes self-management education to ensure that persons with 34diabetes are educated on the proper self-management and treatment of 35diabetes, including, but not limited to, information on proper diets 1provided by a healthcare provider who has been appropriately trained as 2specified in rules and regulations adopted by the board of healing arts.3(d) Any provider of coverage for accident and health services 4described in subsection (a) shall provide an appeals process for covered 5persons who are not able to take one or more of the prescription insulin 6drugs described in subsection (c)(1). Such appeals process shall be 7provided in writing and provide covered persons and the covered person's 8healthcare providers a meaningful opportunity to participate in the appeals 9process.10(e) (1) The commissioner of insurance shall adopt rules and 11regulations as necessary to implement the provisions of this section.12(2) The board of healing arts shall adopt rules and regulations to 13establish training requirements for healthcare providers providing diabetes 14self-management education required to be covered under subsection (c)(2).15(f) (1) No contract between a provider of coverage for accident and 16health services described in subsection (a) and a pharmacy benefits 17manager, as defined in K.S.A. 40-3822, and amendments thereto, shall 18contain any provision that allows any charge, collection or other required 19payment that exceeds the limitations provided in subsection (b).20(2) A pharmacy benefits manager, a provider of coverage for accident 21and health services described in subsection (a) or any other third party that 22reimburses a pharmacy for drugs or services shall not reimburse a 23pharmacy at a lower rate or assess any fee, charge-back or adjustment 24upon a pharmacy on the basis that a covered person's cost-sharing 25requirements are being affected.26(g) As used in this section:27(1) "Device" means a blood glucose test strip, glucometer, continuous 28glucose monitor and transmitter, lancet, lancing device or insulin syringe 29used to cure, diagnose, mitigate, prevent or treat diabetes or low blood 30sugar. "Device" does not include an insulin pump.31(2) "Prescription insulin drug" means a prescription drug that 32contains insulin and is used to treat diabetes.33(h) The provisions of K.S.A. 40-2248, 40-2249 and 40-2249a, and 34amendments thereto, shall not apply to this section.35Sec. 2. This act shall take effect and be in force from and after its 36publication in the statute book. search keyboard_arrow_up keyboard_arrow_down Page 1 Page 2 arrow_upward Top Kansas State Legislature

    300 SW 10th Ave, Topeka, KS 66612

    Ad Astra Per Aspera

    Kansas Legislative Hotline
    In-State: 1-800-432-3924
    Out-of-State: 785-296-2149

    Government

    • Legislators
    • House
    • Representatives
    • Senate
    • Senators
    • Committees

    Resources

    • Bills & Measures
    • Today
    • Live
    • Journals
    • Calendars
    • Archived Records
    • Laws
    • Search
    • RSS Feeds

    Support

    • Contact Us
    • Accessibility
    • Privacy Policy
    • Visit Us
    © 2026 Kansas State Legislature. All rights reserved. Data updated 0 minutes ago · 3:45 PM 11/14/2026

    Texto oficial de la Legislatura de Kansas. El formato se adaptó para leerlo en Ratifi.